415 results on '"Vreeland, Timothy J."'
Search Results
2. Correction: Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
3. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm
4. Circulating Tumor DNA: Towards More Individualized Treatment for Patients with Resectable Colorectal Cancer
5. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases
6. Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma
7. ASO Visual Abstract: Standardization of Colon Resection for Cancer—An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
8. Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
9. SAGES/AHPBA guidelines for the use of minimally invasive surgery for the surgical treatment of colorectal liver metastases (CRLM)
10. Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer
11. Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
12. Minimally invasive versus open distal pancreatectomy: a matched analysis using ACS-NSQIP
13. ASO Visual Abstract: Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Non-metastatic Pancreatic Adenocarcinoma
14. Parenchymal Preservation in the Operative Management of Colorectal Liver Metastases
15. Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival
16. Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention
17. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases
18. Surgical Society Podcasts: A Novel Way to Engage and Educate the Community
19. Iatrogenic Inferior Vena Cava Injury in the Reoperative Foregut: a Technique for Minimally Invasive Repair
20. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
21. Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy
22. The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy
23. Impact of Hepatic Metastasectomy in the Multimodal Treatment of Metastatic Breast Cancer
24. ASO Visual Abstract: Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer
25. A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
26. Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer
27. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes
28. Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer
29. Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement
30. Using Technology to Maintain the Education of Residents During the COVID-19 Pandemic
31. Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge
32. Tumor Lysate Particle Only Vaccine (TLPO) vs. Tumor Lysate Particle-Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in Resected Stage III/IV Melanoma Patients: Results of a Phase I/IIa Trial
33. Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients
34. The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients
35. Examining Perioperative Risk Associated with Simultaneous Resection of Primary Neuroendocrine Tumors and Synchronous Hepatic Metastases
36. Post-operative outcomes for patients with liver-related ascites undergoing non-emergent laparoscopic cholecystectomy
37. Chemoprevention in familial adenomatous polyposis: past, present and future
38. ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma
39. Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
40. Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation
41. Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer
42. Therapeutic Cancer Vaccines for Melanoma
43. Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors
44. ASO Visual Abstract: Standardization of Colon Resection for Cancer—An Overview of the American College of Surgeons Commission on Cancer Standard 5.6
45. Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence – Implications for vaccine trial design
46. Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39’: An analysis of safety and immune response
47. Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors
48. Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference?
49. ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
50. Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.